JNJ
JOHNSON & JOHNSON
NYSE · Healthcare · Drug Manufacturers - General · US
$268.48
+0.87%Leverage
- Debt / equity
- 0.55x
- Net debt / equity
- 0.34x
- Debt / assets
- 0.23x
- Debt / EBITDA
- 1.45x
- Net debt / EBITDA
- 0.90x
Liquidity & coverage
- Current ratio
- 1.02x
- Quick ratio
- 0.74x
- Cash ratio
- 0.31x
- Interest coverage
- 31.99x
- EBITDA / interest
- 38.61x
- Working capital
- $894.0M
Cash & dividend
- FCF / debt
- 0.46x
- Cash flow / debt
- 0.59x
- Dividend per share
- $5.28
- Dividend yield
- 2.0%
- Dividend growth 1y
- +4.7%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026